Pulling SEC filings + quote and writing the call…
Pulling SEC filings + quote and writing the call…

Genprex, Inc.
Next earnings Aug 12, 2026
Conservative balance sheet (liabilities/equity 0.28x).
Genprex, Inc. shows $0.00 in FY2024 revenue, and -203.8% ROE.
Sources: SEC EDGAR (CIK 0001595248, latest 10-Q filed 2026-05-13) · EODHD · as of 6/22/2026, 12:17:17 PM.
Research and education only — not financial advice. Calls are generated from SEC filings and a delayed/third-party price feed, may be wrong or out of date, and are not a recommendation to buy or sell any security. Do your own research.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro€15/mo · cancel anytime
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$20.7M | -$23.8M | -$31.1M | -$21.2M | -$15.5M |
| Net income | -$20.7M | -$23.7M | -$30.9M | -$21.1M | -$16.2M |
| Diluted EPS | -$0.42 | — | — | — | — |
| Net margin | — | — | — | — | — |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
2 buys · 1 member · last 180d
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
1483 tracked peers · median
Last 90 days: 0 open-market buys · 2 sales
| 2026-04-14 | LONGNECKER BRENT M Director | Sell | 8.00 @ $1.23 | $9.84 |
| 2026-04-14 | LONGNECKER BRENT M Director | Sell | 10.00 @ $1.23 | $12.30 |
| 2026-02-27 | Berger Mark Stanley Chief Medical Officer | Tax | 7.17K @ $2.00 | $14.3K |
| 2026-02-27 | Confer Ryan M. President, CEO and CFO | Tax | 9.33K @ $2.00 | $18.7K |
| 2025-12-22 | Moreno Toscano Jose Antonio Director | Award | 9.00K | |
| 2025-12-22 | Berger Mark Stanley Chief Medical Officer | Award | 28.5K | |
| 2025-12-22 | Confer Ryan M. President, CEO and CFO | Award | 45.0K | |
| 2025-12-22 | LONGNECKER BRENT M Director | Award | 9.00K | |
| 2025-12-22 | Wilson William R Jr. Director | Award | 9.00K |